Nosocomial pneumonia remains one of the most common, costly, and deadly hospital-acquired infections worldwide.¹ Ventilator-associated pneumonia accounts for about half of all hospital-acquired pneumonias and is the second most common nosocomial infection in patients in the intensive-care unit.^1,2 Despite extensive work to prevent ventilator-associated pneumonia, an audit by the US Centers for Medicare and Medicaid Services showed no meaningful decrease in the frequency of the infection in US hospitals during the past decade.

中文翻译：

---

头孢他啶-阿维巴坦与美罗培南治疗院内肺炎

医院内肺炎仍然是全球范围内最常见，成本最高和致命的医院获得性感染之一。^1与呼吸机相关的肺炎约占所有医院获得性肺炎的一半，并且是重症监护病房患者中第二常见的医院内感染。^1,2尽管为预防呼吸机相关性肺炎开展了广泛的工作，但美国医疗保险和医疗补助服务中心的一项审核显示，过去十年来，美国医院的感染频率没有任何有意义的下降。